News

All News

Breast Cancer Risk Stratification for Hormone Replacement Therapy

Breast Cancer Risk Stratification for Hormone Replacement Therapy 

In one of the largest studies on hormone replacement therapy and breast cancer, Ningqi Hou, Jim Dignam, and Dezheng Huo, researchers in the Department of Health Studies at the University of Chicago, found that there was a differential risk associated with hormone replacement therapy according to women’s body mass index, breast density, and race/ethnicities. Read more…